Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


X0202 SCHEDULE 13D/A 0001749628 XXXXXXXX LIVE 6 Ordinary shares, par value NIS 0.20 per share 09/08/2026 false 0001574565 M4119S187 Evogene Ltd. 13 Gad Feinstein Street Park Rehovot, Rehovot L3 7638517 Kfir Silberman 972-3-7175777 L.I.A. Pure Capital Ltd 20 Raoul Wallenberg Street Tel Aviv L3 6971916 0001749628 N L.I.A. Pure Capital Ltd. b WC N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 19.35 CO (1) The percentage of ordinary shares, par value NIS 0.20 per share, of Evogene Ltd. (the "Ordinary Shares" and the "Issuer", respectively) beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026. Y Kfir Silberman b AF N L3 0.00 3057488.00 2557488.00 0.00 3057488.00 N 19.35 IN (1) The securities reported on this Schedule are held by L.I.A. Pure Capital Ltd. ("Pure Capital"). Kfir Silberman is the officer, sole director, chairman of the board of directors and controlling shareholder of Pure Capital. (2) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026. 0002110772 N Invest Pro Shukai Hon Ltd. b AF N L3 0.00 3057488.00 500000.00 0.00 3057488.00 N 19.35 CO (1) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026. Y Ron Yair Peled b AF N L3 0.00 3057488.00 500000.00 0.00 3057488.00 N 19.35 IN (1) The securities reported on this Schedule are held by Invest Pro Shukai Hon Ltd. ("Invest Pro"). Ron Yair Peled is the owner and the Chief Executive Officer of Invest Pro. (2) The percentage of Ordinary Shares beneficially owned by the Reporting Person is based on 15,801,407 Ordinary Shares outstanding as of July 27, 2026, as reported by the Issuer in the Issuer's Proxy Statement for its 2026 Annual General Meeting of Shareholders, dated July 31, 2026, attached as Exhibit 99.2 to the Issuer's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on July 31, 2026. Ordinary shares, par value NIS 0.20 per share Evogene Ltd. 13 Gad Feinstein Street Park Rehovot, Rehovot L3 7638517 The following constitutes Amendment No. 6 ("Amendment No. 6") to the Schedule 13D previously filed by the undersigned on July 10, 2026 and amended by Amendment No. 1 on July 20, 2026, by Amendment No. 2 on July 27, 2026, by Amendment No. 3 on August 7, 2026, by Amendment No. 4 on August 13, 2026 and by Amendment No. 5 on August 28, 2026 (as amended, the "Schedule 13D"). This Amendment No. 6 amends the Schedule 13D as specifically set forth herein. Each capitalized term used and not defined herein shall have the meaning assigned to such term in the Schedule 13D. Except as provided herein, each Item of the Schedule 13D remains unchanged. This Amendment No. 6 is being filed to report that the Reporting Persons notified the Issuer of their intention to commence a special tender offer pursuant to Section 328 of the Israeli Companies Law, 5759-1999. Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On September 8, 2026, the Reporting Persons delivered a letter to the Issuer notifying the Issuer that they, acting individually or jointly, intend to commence a special tender offer pursuant to Section 328 of the Israeli Companies Law, 5759-1999, which, if consummated, would result in the Reporting Persons holding, in the aggregate, not less than 25% of the Issuer's outstanding voting rights. A copy of the letter is attached hereto as Exhibit 9 and is incorporated herein by reference. Item 7 is hereby amended to add the following exhibit: Exhibit 9 - Letter from the Reporting Persons to the Issuer, dated September 8, 2026 L.I.A. Pure Capital Ltd. /s/ Kfir Silberman Kfir Silberman/Chairman and Chief Executive Officer 09/11/2026 Kfir Silberman /s/ Kfir Silberman Kfir Silberman 09/11/2026 Invest Pro Shukai Hon Ltd. /s/ Eli Zamir Eli Zamir/Director 09/11/2026 Ron Yair Peled /s/ Ron Yair Peled Ron Yair Peled 09/11/2026